Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Non-invasive wireless blood gas and respiratory monitoring system

Reference number
Coordinator NovoSense AB
Funding from Vinnova SEK 4 821 264
Project duration September 2015 - April 2018
Status Completed
Venture Eurostars

Purpose and goal

The project goal is to develop a wireless non-invasive system for monitoring blood gas and respiration. The proposed medical device system will maximize market penetration for Novosense´s already developed ECG monitoring system. Providing a complete monitoring system has been identified as important for breaking existing market barriers.

Expected results and effects

Novosense, together with a Norwegian partner, Novelda, has developed a new type of wireless sensor system for monitoring blood gas and respiration. The next step for the product is clinical trial and then launched internationally with start in Scandinavia. The end consumer is primarily intensive care units.

Planned approach and implementation

Two companies, Novelda AS, Norway and Novosense AB, Sweden, have collaborated to develop a new medicine device product. Novelda has developed a miniature UWB radar sensor for non-invasive monitoring of respiration. Novosense has developed a wireless blood gas sensor as well as the integration of the wireless sensors into the monitoring system.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 3 December 2018

Reference number 2015-04115

Page statistics